Activities of Daptomycin and Vancomycin Alone and in Combination with Rifampin and Gentamicin against Biofilm-Forming Methicillin-Resistant Staphylococcus aureus Isolates in an Experimental Model of Endocarditis
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
The findings of clinical and in vitro research support the theory that infective endocarditis (IE)-causing bacteria form biofilms and that biofilms negatively affect treatment outcomes. The purpose of the present study was to quantify the biofilm formation of methicillin (meticillin)-resistant Staphylococcus aureus (MRSA) isolates obtained from patients with IE and to evaluate the in vitro activities of daptomycin and vancomycin alone and in combination with rifampin (rifampicin) or gentamicin while monitoring the isolates for the development of resistance. A high-inoculum, stationary-phase infection model of IE was used to simulate the pharmacokinetics in humans of daptomycin at 6 mg/kg of body weight/day, vancomycin at 1.25 g every 12 h (q12h) alone and in combination with rifampin at 300 mg every 8 h, and gentamicin at 1.3 mg/kg q12h. Two randomly selected clinical MRSA isolates were obtained from patients with IE; both MRSA isolates quantitatively produced biofilms. The time to bactericidal activity in the presence of daptomycin was isolate dependent but was achieved by 24 h for both MRSA isolates. Vancomycin did not achieve bactericidal activity throughout the experiment. At 24, 48, and 72 h, daptomycin-containing regimens had significantly more activity (greater declines in the mean number of CFU/g) than any of the vancomycin-containing regimens ( P = 0.03). Rifampin and gentamicin antagonized or delayed the bactericidal activity of daptomycin (against MRSA B346846 for rifampin and against both isolates for gentamicin) in the first 24 h. Increases in the daptomycin and vancomycin MICs were not observed. We conclude that in an IE model of biofilm-forming MRSA, daptomycin monotherapy has better in vitro activity than daptomycin in combination with rifampin or gentamicin or any vancomycin-containing regimen studied within the first 24 h. Further investigations are needed to understand the initial delay in bactericidal activity observed when gentamicin or rifampin is combined with daptomycin.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Importantly, fluoroquinolones and aminoglycoside antibiotics are less affected by the size of the inoculum because of their different mechanisms of bactericidal activity. 81,82”
Citations
Cites
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Medical Entomology and Zoology · Cited by 17,248
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
Principles and Practice of Infectious Diseases.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-818_5 · Cited by 12,025
Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms
Donlan, R. M., & Costerton, J. W. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.167-193.2002 · Cited by 6,644 · cited 2×
“The exact cause of most treatment failures is unknown; however, it is likely related to the ability of the bacteria to form biofilms (14, 19).”
BackgroundSTEPANOVIĆ, S., VUKOVIĆ, D., HOLA, V., BONAVENTURA, G. D., DJUKIĆ, S., ĆIRKOVIĆ, I., & RUZICKA, F. (2007) · APMIS · doi:10.1111/j.1600-0463.2007.apm_630.x · Cited by 2,494
Ceri, H., Olson, M. E., Stremick, C., Read, R. R., Morck, D., & Buret, A. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.6.1771-1776.1999 · Cited by 2,155
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Bolger, A. F., Levison, M. E., Ferrieri, P., Gerber, M. A., Tani, L. Y., Gewitz, M. H., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.165564 · Cited by 1,707
Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by Staphylococcus aureus
Fowler, V. G., Boucher, H. W., Corey, G. R., Abrutyn, E., Karchmer, A. W., Rupp, M. E., Levine, D. P., Chambers, H. F., Tally, F. P., Vigliani, G. A., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053783 · Cited by 1,459
Götz, F. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.02827.x · Cited by 1,178
Staphylococcus aureus Endocarditis: A Consequence of Medical Progress
Fowler, V. G., Miro, J. M., Hoen, B., Cabell, C. H., Abrutyn, E., Rubinstein, E., Corey, G. R., Spelman, D., Bradley, S. F., Barsic, B., et al. (2005) · JAMA · doi:10.1001/jama.293.24.3012 · Cited by 1,174
Research works printed but not linked: 2
- Performance standards for antimicrobial susceptibility testing; 16th informational supplement. 2006 vol. 26
- 10.1172/jci20442 · doi:10.1172/jci20442 · Paper page
Cited by
Tong, S. Y. C., Davis, J. S., Eichenberger, E., Holland, T. L., & Fowler, V. G. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00134-14 · Cited by 5,192
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Tleyjeh, I. M., Rybak, M. J., Barsic, B., Lockhart, P. B., Gewitz, M. H., Levison, M. E., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000296 · Cited by 3,232
New approaches for treating staphylococcal biofilm infections
Kiedrowski, M. R., & Horswill, A. R. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06281.x · Cited by 288
Anti-biofilm Activity as a Health Issue
Miquel, S., Lagrafeuille, R., Souweine, B., & Forestier, C. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00592 · Cited by 225
JCS 2017 Guideline on Prevention and Treatment of Infective Endocarditis
Nakatani, S., Ohara, T., Ashihara, K., Izumi, C., Iwanaga, S., Eishi, K., Okita, Y., Daimon, M., Kimura, T., Toyoda, K., et al. (2019) · Circulation Journal · doi:10.1253/circj.cj-19-0549 · Cited by 179
Current concepts on the virulence mechanisms of meticillin-resistant Staphylococcus aureus
Watkins, R. R., David, M. Z., & Salata, R. A. (2012) · Journal of Medical Microbiology · doi:10.1099/jmm.0.043513-0 · Cited by 178
Daptomycin Nonsusceptible Enterococci: An Emerging Challenge for Clinicians
Kelesidis, T., Humphries, R., Uslan, D. Z., & Pegues, D. A. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq113 · Cited by 146
Bauer, J., Siala, W., Tulkens, P. M., & Van Bambeke, F. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00181-13 · Cited by 130
Parra-Ruiz, J., Vidaillac, C., Rose, W. E., & Rybak, M. J. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00455-10 · Cited by 138
Mihăilescu, R., Tafin, U. F., Corvec, S., Oliva, A., Bétrisey, B., Borens, O., & Trampuž, A. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02420-12 · Cited by 129
Siala, W., Mingeot-Leclercq, M.-P., Tulkens, P. M., Hallin, M., Denis, O., & Van Bambeke, F. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03482-14 · Cited by 110
Chen, X., Thomsen, T. R., Winkler, H., & Xu, Y. (2020) · BMC Microbiology · doi:10.1186/s12866-020-01947-9 · Cited by 124
Analysis of Bacterial Biofilms Using NMR-Based Metabolomics
Zhang, B., & Powers, R. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.59 · Cited by 122
Combination Antibiotic Treatment of Serious Methicillin-Resistant Staphylococcus aureus Infections
van Hal, S. J., Tong, S. Y. C., & Davis, J. S. (2015) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0034-1396906 · Cited by 119
Management of Staphylococcus aureus bacteremia and endocarditis: progresses and challenges
Kern, W. V. (2010) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e32833bcc8a · Cited by 102
Zhao, F., Su, Y., Wang, J., Romanova, S., DiMaio, D. J., Xie, J., & Zhao, S. (2022) · Advanced Materials · doi:10.1002/adma.202208069 · Cited by 105
Staphylococcus aureus Biofilms and their Impact on the Medical Field
Reffuveille, F., Josse, J., Vallé, Q., Mongaret, C., & Gangloff, S. C. (2017) · InTech eBooks · doi:10.5772/66380 · Cited by 91
Vanamala, K., Tatiparti, K., Bhise, K., Sau, S., Scheetz, M. H., Rybak, M. J., Andes, D. R., & Iyer, A. K. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.10.011 · Cited by 87
Garrigós, C., Murillo, Ó., Euba, G., Verdaguer, R., Tubau, F., Cabellos, C., Cabo, J., & Ariza, J. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00226-10 · Cited by 83
Luther, M. K., Arvanitis, M., Mylonakis, E. E., & LaPlante, K. L. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02790-13 · Cited by 81
Self-citationSeidl, K., Bayer, A. S., Fowler, V. G., McKinnell, J. A., Abdel Hady, W., Sakoulas, G., Yeaman, M. R., & Xiong, Y. Q. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01028-10 · Cited by 69
Phage Therapy as a Novel Therapeutic for the Treatment of Bone and Joint Infections
Suh, G. A., Ferry, T., & Abdel, M. P. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad533 · Cited by 68
Penetration of Daptomycin into Bone and Synovial Fluid in Joint Replacement
Montange, D., Berthier, F., Leclerc, G., Serre, A., Jeunet, L., Bérard, M., Muret, P., Vettoretti, L., Leroy, J., Hoen, B., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02344-14 · Cited by 62
Entenza, J. M., Giddey, M., Vouillamoz, J., & Moreillon, P. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.12.022 · Cited by 61
Kelesidis, T., Humphries, R. M., Ward, K. W., Lewinski, M. A., & Yang, O. O. (2011) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2011.07.001 · Cited by 59
Barber, K. E., Smith, J. R., Ireland, C. E., Boles, B. R., Rose, W. E., & Rybak, M. J. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00386-15 · Cited by 57
Esposito, S., Purrello, S., Bonnet, É., Novelli, A., Tripodi, F., Pascale, R., Ünal, S., & Milkovich, G. (2013) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2013.03.002 · Cited by 57
García-de-la-Mària, C., Gasch, O., García‐González, J., Soy, D., Shaw, E., Ambrosioni, J., Almela, M., Pericàs, J. M., Téllez, A., Falces, C., et al. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02633-17 · Cited by 55
Olson, M. E., Slater, S. R., Rupp, M. E., & Fey, P. D. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq314 · Cited by 55
Boudjemaa, R., Briandet, R., Revest, M., Jacqueline, C., Caillon, J., Fontaine‐Aupart, M., & Steenkeste, K. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00735-16 · Cited by 54
Clinical and Genetic Risk Factors for Biofilm-Forming Staphylococcus aureus
Luther, M. K., Parente, D. M., Caffrey, A. R., Daffinee, K. E., Lopes, V., Martin, E. T., & LaPlante, K. L. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02252-17 · Cited by 51
Self-citationShi, J., Mao, N., Wang, L., Zhang, H., Chen, Q., Liu, H., Tang, X., Jin, T., Zhu, C., Li, F., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113133 · Cited by 50
Daptomycin use in patients with osteomyelitis: a preliminary report from the EU-CORESM database
Seaton, R. A., Malizos, K. N., Viale, P., Gargalianos-Kakolyris, P., Santantonio, T. A., Petrelli, E., Pathan, R., Heep, M., & Chaves, R. L. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt067 · Cited by 50
Abbanat, D., Shang, W., Amsler, K. M., Santoro, C. M., Baum, E., Crespo‐Carbone, S. M., & Lynch, A. S. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.09.013 · Cited by 45
Shaw, E., Miró, J. M., Puig‐Asensio, M., Pigrau, C., Barcenilla, F., Murillas, J., García‐Pardo, G., Espejo, E., Padilla, B., García‐Reyne, A., et al. (2015) · BMJ Open · doi:10.1136/bmjopen-2014-006723 · Cited by 47
A multilayered electrospun graft as vascular access for hemodialysis
Radaković, D., Reboredo, J. W., Helm, M., Weigel, T., Schürlein, S., Kupczyk, E. K., Leyh, R. G., Walles, H., & Hansmann, J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185916 · Cited by 45
Lee, Y., Chen, P., Wang, J., & Chang, S. (2019) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-019-0305-y · Cited by 43
Broussou, D. C., Lacroix, M. Z., Toutain, P., Woehrlé, F., Garch, F. E., Bousquet‐mélou, A., & Ferran, A. A. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00572 · Cited by 41
Falcone, M., Russo, A., & Venditti, M. (2015) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2015.02.012 · Cited by 42
Smani, Y., Domínguez-Herrera, J., & Pachón, J. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiq159 · Cited by 40
Berlon, N. R., Qi, R., Sharma‐Kuinkel, B. K., Joo, H., Park, L. P., George, D., Thaden, J. T., Messina, J. A., Maskarinec, S. A., Mueller‐Premru, M., et al. (2015) · Journal of Infection · doi:10.1016/j.jinf.2015.06.005 · Cited by 39
Salem, A. H., Elkhatib, W. F., & Noreddin, A. M. (2010) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2010.01183.x · Cited by 36
Safety of treatment with high-dose daptomycin in 102 patients with infective endocarditis
Durante‐Mangoni, E., Andini, R., Parrella, A., Mattucci, I., Cavezza, G., Senese, A., Trojaniello, C., Caprioli, R., Diana, M. V., & Utili, R. (2016) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.04.022 · Cited by 36
Jahanbakhsh, S., Singh, N. B., Yim, J., Kebriaei, R., Smith, J. R., Lev, K. L., Tran, T. T., Rose, W. E., Arias, C. A., & Rybak, M. J. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02074-19 · Cited by 35
Chronic equine wounds: what is the role of infection and biofilms?.
Westgate, S. J., Percival, S. L., Knottenbelt, D. C., Clegg, P., & Cochrane, C. A. (2010) · PubMed · Cited by 35
Legout, L., D’Elia, P., Sarraz-Bournet, B., Rouyer, C., Massongo, M., Valette, M., Leroy, O., Haulon, S., & Senneville, É. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-228 · Cited by 35
Random peptide mixtures inhibit and eradicate methicillin-resistant Staphylococcus aureus biofilms
Stern, T., Zelinger, E., & Hayouka, Z. (2016) · Chemical Communications · doi:10.1039/c6cc01438k · Cited by 26
Tonnelier, M., Bouras, A., Joseph, C., Samad, Y. E., Brunschweiler, B., Schmit, J. L., Mabille, C., & Lanoix, J. P. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-05832-2 · Cited by 26
Jones, R. N., Stilwell, M. G., Wilson, M. L., & Mendes, R. E. (2013) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2013.01.023 · Cited by 25
Antibiotic Combinations with Daptomycin for Treatment of Staphylococcus aureus Infections
Nadrah, K., & Strle, F. (2011) · Chemotherapy Research and Practice · doi:10.1155/2011/619321 · Cited by 25
Öztürk, B., Günay, N., Ertuğrul, B., & Sakarya, S. (2016) · Canadian Journal of Microbiology · doi:10.1139/cjm-2015-0855 · Cited by 24
Shaban, T. F., & Alkawareek, M. Y. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2021.105065 · Cited by 23
Guleri, A., Utili, R., Dohmen, P. M., Petrosillo, N., Piper, C., Pathan, R. B., & Hamed, K. A. (2015) · Infectious Diseases and Therapy · doi:10.1007/s40121-015-0075-9 · Cited by 24
Plota, M., Sazakli, E., Giormezis, N., Gkartziou, F., Kolonitsiou, F., Leotsinidis, M., Antimisiaris, S. G., & Spiliopoulou, I. T. (2021) · Microorganisms · doi:10.3390/microorganisms9091853 · Cited by 22
Combination antibiotic therapy for the treatment of infective endocarditis due to enterococci
Leone, S., Noviello, S., & Esposito, S. (2015) · Infection · doi:10.1007/s15010-015-0836-0 · Cited by 22
Atwood, D. N., Beenken, K. E., Loughran, A. J., Meeker, D. G., Lantz, T. L., Graham, J. W., Spencer, H. J., & Smeltzer, M. S. (2016) · Infection and Immunity · doi:10.1128/iai.01462-15 · Cited by 22
Polymicrobial Biofilm Inhibition Effects of Acetate‐Buffered Chitosan Sponge Delivery Device
Jennings, J. A., Beenken, K. E., Parker, A. C., Smith, J. K., Courtney, H. S., Smeltzer, M. S., & Haggard, W. O. (2016) · Macromolecular Bioscience · doi:10.1002/mabi.201500347 · Cited by 21
Thiyagarajan, D., Das, G. C., & Ramesh, A. (2017) · ChemMedChem · doi:10.1002/cmdc.201700260 · Cited by 20
Gidari, A., Sabbatini, S., Schiaroli, E., Perito, S., Francisci, D., Baldelli, F., & Monari, C. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.02085 · Cited by 19
Luther, M. K., & LaPlante, K. L. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01604-15 · Cited by 19
Self-citationMarsot, A., Menard, A., Dupouey, J., Muziotti, C., Guilhaumou, R., & Blin, O. (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13178 · Cited by 18
Daptomycin synergistic properties from in vitro and in vivo studies: a systematic review
Antonello, R. M., Canetti, D., & Riccardi, N. (2022) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkac346 · Cited by 17
Blaznik, M., Volk, M., Kraigher, B., Calonge-Sanz, A., Barco-García, G., Stopar, D., & Dogša, I. (2025) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00864-x · Cited by 16
Jiang, J., & Peleg, A. Y. (2015) · Genes · doi:10.3390/genes6041256 · Cited by 17
Lübbert, C., Rodloff, A. C., & Hamed, K. A. (2015) · Infectious Diseases and Therapy · doi:10.1007/s40121-015-0072-z · Cited by 16
Stockmann, C. R., Roberts, J. K., Tian, Y., Constance, J. E., Knibbe, C. A. J., Spigarelli, M. G., & Sherwin, C. M. T. (2014) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2014.966081 · Cited by 16
Dey, P., Mukherjee, S., Das, G. C., & Ramesh, A. (2018) · Journal of Materials Chemistry B · doi:10.1039/c7tb03150e · Cited by 16
Daffinee, K. E., Piehl, E. C., Bleick, C. R., & LaPlante, K. L. (2023) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00108-23 · Cited by 15
Self-citationLiu, J., Gefen, O., Zhang, Z., Liu, M., Bar‐Meir, M., & Balaban, N. Q. (2022) · mBio · doi:10.1128/mbio.00004-22 · Cited by 13
Jobson, S., Moise, P. A., & Eskandarian, R. (2011) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.09.007 · Cited by 12
Use of daptomycin in complicated cases of infective endocarditis
Das, I., Saluja, T., & Steeds, R. P. (2011) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-011-1160-y · Cited by 12
Luther, M. K., Mermel, L. A., & LaPlante, K. L. (2016) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp150029 · Cited by 12
Self-citationYan, Q., Karau, M. J., Raval, Y. S., & Patel, R. (2018) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2018.07.012 · Cited by 11
Treatment of Gram-positive left-sided infective endocarditis with daptomycin
Kaya, S., Yılmaz, G., Kalkan, A., Ertunç, B., & Köksal, İ. (2013) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-012-0546-9 · Cited by 10
Legout, L., D’Elia, P., Sarraz-Bournet, B., Ettahar, N., Haulon, S., Leroy, O., & Senneville, E. (2014) · Infectious Diseases and Therapy · doi:10.1007/s40121-014-0035-9 · Cited by 11
Luther, M. K., Mermel, L. A., & LaPlante, K. L. (2017) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp150804 · Cited by 10
Self-citationTownsend, J. A., & Marty, M. T. (2023) · Methods · doi:10.1016/j.ymeth.2023.07.004 · Cited by 9
Pérez-Alba, E., Flores-Treviño, S., Villarreal-Salazar, V., Bocanegra‐Ibarias, P., Vílchez‐Cavazos, F., & Camacho-Ortíz, A. (2023) · Journal of Applied Microbiology · doi:10.1093/jambio/lxad258 · Cited by 9
Billups, K. L., & Stultz, J. S. (2015) · The Journal of Pediatric Pharmacology and Therapeutics · doi:10.5863/1551-6776-20.5.397 · Cited by 9
Ang, M. Y., & Choo, S. W. (2026) · Biology · doi:10.3390/biology15080632 · Cited by 7
Golikova, M. V., Strukova, E. N., Абрамович, П. Ю., Zinner, S. H., & Firsov, A. A. (2020) · Antibiotics · doi:10.3390/antibiotics9090538 · Cited by 7
Yim, J., Smith, J. R., Barber, K. E., Hallesy, J. A., & Rybak, M. J. (2016) · Infectious Diseases and Therapy · doi:10.1007/s40121-016-0121-2 · Cited by 7
Turnidge, J. D. (2013) · Springer eBooks · doi:10.1007/978-0-387-75613-4_8 · Cited by 6
Golikova, M. V., Strukova, E. N., Абрамович, П. Ю., Zinner, S. H., & Firsov, A. A. (2019) · The Journal of Antibiotics · doi:10.1038/s41429-019-0249-x · Cited by 6
Leung, Y. K. S., Ledergerber, B., Eberhard, N., Mestres, C. A., Rančić, Z., Zimmermann, A., Zbinden, R., Brugger, S. D., Zinkernagel, A. S., Hasse, B. K., et al. (2021) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlab041 · Cited by 5
Vandenhende, M. A., Buret, J., Camou, F., Morlat, P., & Bonnet, F. (2014) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2014.01.006 · Cited by 5
Argemi, X., Hansmann, Y., Christmann, D., Lefebvre, S., Jaulhac, B., & Jehl, F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064218 · Cited by 5
Mbuku, R. B., Poilvache, H., Maigret, L., Vanbever, R., Bambeke, F. V., & Cornu, O. (2026) · npj Biofilms and Microbiomes · doi:10.1038/s41522-026-00910-2 · Cited by 4
Marbach, H., Boakes, E., Lynham, S., Ward, M. A., Otter, J. A., & Edgeworth, J. D. (2017) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000470 · Cited by 4
Chauhan, P., Dey, P., Mukherjee, S., Manna, U., Das, G. C., & Ramesh, A. (2018) · ChemistrySelect · doi:10.1002/slct.201702842 · Cited by 4
Boudjemaa, R., Briandet, R., Fontaine‐Aupart, M., & Steenkeste, K. (2017) · Photochemical & Photobiological Sciences · doi:10.1039/c7pp00079k · Cited by 4
Oubekka, S. D. (2012) · theses.fr (ABES) · doi:10.70675/9d8dc787zd26ez48b4z9beczceb548d34c8d · Cited by 4
Reviving Old Antibiotics: New Indications and Therapeutic Perspectives—A Review
Radkowski, P., Oszytko, J., Sobolewski, K., Trachte, F., Czerwińska-Rogowska, M., Onichimowski, D., & Majewska, M. (2026) · Pharmaceuticals · doi:10.3390/ph19020278 · Cited by 3
Global Trends in Orthopedic Biofilm Research: A Bibliometric Analysis of 1994-2022
Hu, Z., Yin, X., Fan, G., & Liao, X. (2024) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s465632 · Cited by 3
Marsot, A., Menard, A., Dupouey, J., Allanioux, L., Blin, O., & Guilhaumou, R. (2020) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14319 · Cited by 3
Wojtyczka, R. D., Zięba, A., Dziedzic, A. M., Kępa, M., & Idzik, D. (2015) · BioMed Research International · doi:10.1155/2015/725939 · Cited by 3
Wilkinson, A. J. (2016) · ERA · Cited by 3
Lipopeptide Engineering: From Natural Origins to Rational Design Against Antimicrobial Resistance
Xie, S.-Y., He, F.-J., Yang, Y.-Y., Tao, Y., & Wang, X. (2026) · Antibiotics · doi:10.3390/antibiotics15010100 · Cited by 2
Jalal, Z., Roubertie, F., Iriart, X., Thambo, J., & Camou, F. (2015) · Journal of Pediatric Infectious Diseases · doi:10.3233/jpi-130391 · Cited by 2
Traitement des infections de prothèse vasculaire
Camou, F., Legout, L., Caillon, J., Laurent, F. J., Sobocinski, J., & Leroy, O. (2016) · Réanimation · doi:10.1007/s13546-016-1176-5 · Cited by 3
Metadata
- Authors
- LaPlante, K. L., & Woodmansee, S.
- Affiliations
- University of Rhode Island (US)
- Providence VA Medical Center (US)
- Corresponding author
- LaPlante, Kerry L.
- ORCID
- LaPlante, Kerry L.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2009-09
- Volume
- 53
- Issue
- 9
- Pages
- 3880-3886
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC2737833
- OpenAlex
- W2133736791
- Semantic Scholar
- 493a2fe713337d2af29722aa84a1ae225e629305
- Cited by
- 110
- References
- 44
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 1 · 2023: 5 · 2022: 3 · 2021: 5 · 2020: 6 · 2019: 3 · 2018: 7 · 2017: 6 · 2016: 11 · 2015: 15 · 2014: 11 · 2013: 8 · 2012: 5
- FWCI
- 5.15
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Journal of Media Literacy Education (submittedVersion, cc-by)
- Funders
- U.S. Department of Veterans Affairs
- University of Wisconsin-Madison
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Keywords
- daptomycin, vancomycin, rifampicin, gentamicin, methicillin-resistant Staphylococcus aureus, infective endocarditis, biofilm formation, combination antibiotic therapy, bactericidal activity, antibiotic resistance development, in vitro antimicrobial susceptibility, monotherapy versus combination therapy
- MeSH terms
- Anti-Bacterial Agents, Endocarditis, Gentamicins, Humans, Microbial Sensitivity Tests, Rifampin, Vancomycin, Daptomycin, Biofilms, Methicillin-Resistant Staphylococcus aureus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.